A phase I study of SR-4554 via intravenous administration for noninvasive investigation of tumor hypoxia by magnetic resonance spectroscopy in patients with malignancy.

Seddon, Beatrice M; Payne, Geoffrey S; Simmons, Laura; Ruddle, Ruth; Grimshaw, Rachel; Tan, Siew; Turner, Alison; Raynaud, Florence; Halbert, Gavin; Leach, Martin O; Judson, Ian; Workman, Paul

Seddon, Beatrice M; Payne, Geoffrey S; Simmons, Laura; Ruddle, Ruth; Grimshaw, Rachel; Tan, Siew; Turner, Alison; Raynaud, Florence; Halbert, Gavin; Leach, Martin O; Judson, Ian; Workman, Paul.

Affiliation

Seddon BM; Cancer Research UK Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, Surrey, United Kingdom.

Clin Cancer Res ; 9(14): 5101-12, 2003 Nov 01.

Article in En | MEDLINE | ID: mdl-14613987

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Magnetic Resonance Spectroscopy / Biomarkers, Tumor / Hypoxia / Neoplasms / Nitroimidazoles Type of study: Diagnostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2003 Document type: Article Affiliation country: Reino Unido

Search on Google

Add to My VHL

XML

PubMed Links